| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |